{
  "ptid_time": "019_S_4680_2012-07-11",
  "img_path": "/data/qiuhui/data/adni/images/019_S_4680/2012-07-11/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 17,419 mm³, 22.0% below the reference mean. With a Z-score of -0.55 (29.1th percentile), this represents normal volume ; hippocampal volume measures 6,436 mm³, 16.2% below the reference mean. With a Z-score of -1.82 (3.4th percentile), this represents moderate atrophy; whole brain volume measures 874,593 mm³, 15.0% below the reference mean. With a Z-score of -1.87 (3.1th percentile), this represents moderate atrophy; entorhinal cortex volume measures 4,178 mm³, 7.3% above the reference mean. With a Z-score of 0.57 (71.5th percentile), this represents normal volume ; fusiform gyrus volume measures 14,109 mm³, 22.5% below the reference mean. With a Z-score of -2.54 (0.6th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,867 mm³, 22.7% below the reference mean. With a Z-score of -2.02 (2.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 63.4 years. Gender is Female. Education: 19 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 29.0. MoCA: 24.0. Logical Memory: 9.0. APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.38 SUVR (significant elevated); Amyloid beta: 487.90 pg/mL (mild reduced); Total tau: 246.20 pg/mL (normal ); Phosphorylated tau: 24.13 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the fusiform gyrus and middle temporal gyrus, along with moderate hippocampal and whole-brain atrophy, which are typical in early Alzheimer's disease. Despite normal cognitive screening scores (MMSE 29, MoCA 24), the presence of APOE4 homozygosity, mildly reduced Aβ, and significantly elevated AV45 (amyloid PET) strongly suggest amyloid pathology.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI) due to Alzheimer’s disease**  \n**Confidence:** **High**  \n\n*(Note: While cognitive scores are still in the normal range, the combination of structural atrophy, amyloid positivity, and APOE4 homozygosity strongly predicts progression to dementia. A diagnosis of MCI is appropriate given the biomarker evidence of AD pathology.)*",
  "timestamp": "2025-07-26T01:07:41.310910"
}